Transnetyx, INC.:1183655 [19-005819]
Ended Awarded Last action
- Contract number
- 75N92B19F00043
- Awardee
-
Transnetyx, Inc. UEI CNG6DGADGL38
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,899
Award facts
- Contract value 100% obligated
- $23,899.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$726 | |
| Original award | $24,625 |
About this award
Transnetyx, Inc., headquartered in Cordova, Tennessee, was awarded a $23,899.10 firm fixed price Blanket Purchase Agreement call by the National Institute of Arthritis and Musculoskeletal and Skin Diseases on September 16, 2019, with an ultimate completion date of October 31, 2019. The contract, which utilized no set-aside designation and was awarded through open market competition, is to be performed in Bethesda, Maryland. Transnetyx specializes in advanced genetic testing and analysis services for federal research institutions, providing comprehensive genomic services including automated genotyping, DNA extraction, multi-gene analysis, and bioinformatics support for laboratory animals, particularly transgenic rodent models.
This award represents a task order against Transnetyx's larger Blanket Purchase Agreement vehicle with the federal government, reflecting the company's established role as a critical provider of genetic testing services across the National Institutes of Health ecosystem. The contract supports the National Institute of Arthritis and Musculoskeletal and Skin Diseases' research initiatives by delivering specialized genotyping services necessary for ongoing scientific investigations. Transnetyx has successfully maintained a portfolio of federal contract awards across multiple NIH institutes and agencies, demonstrating consistent capability in delivering precise genetic analysis to support diverse research programs examining musculoskeletal health and related scientific domains.
Quick answers
Who was awarded contract 75N92B19F00043?
75N92B19F00043 was awarded to Transnetyx, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 16, 2019.
How much is contract 75N92B19F00043 worth?
The government has obligated $23,899 on 75N92B19F00043.
Is contract 75N92B19F00043 an order under another contract?
Yes. 75N92B19F00043 is a BPA call under HHSN263201100002B, a blanket purchase agreement.
Was contract 75N92B19F00043 competed?
The extent of competition for 75N92B19F00043 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award